Overview
- An international consensus group led by Monash University researchers announced the PMOS name this month after a 14‑year process that gathered input from thousands of patients and clinicians.
- PMOS describes a multisystem hormone disorder that can affect periods, skin, weight, fertility, blood sugar, heart health, sleep, and mood rather than a cyst problem alone.
- Current clinical guidance cited in coverage says adults are diagnosed when at least two findings are present: irregular or absent ovulation, elevated androgens or their symptoms, or polycystic ovaries on ultrasound or high anti‑Müllerian hormone.
- Researchers and clinicians expect a multiyear transition to update guidelines, education, and disease classification, with a push for earlier checks for insulin resistance, diabetes risk, cholesterol, blood pressure, sleep issues, and mental health.
- The scale is large, with WHO estimates of 10% to 13% of women of reproductive age affected and reports of up to 70% going undiagnosed, which leaves many without timely care for treatable symptoms.